Results 51 to 60 of about 100,104 (213)

Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design

open access: yesAdvanced Healthcare Materials, EarlyView.
Antimicrobial peptide (AMP)‐loaded nanocarriers provide a multifunctional strategy to combat drug‐resistant Mycobacterium tuberculosis. By enhancing intracellular delivery, bypassing efflux pumps, and disrupting bacterial membranes, this platform restores phagolysosome fusion and macrophage function.
Christian S. Carnero Canales   +11 more
wiley   +1 more source

Development of the novel Pictor PictVet™ Mycoplasma bovis IgG multiplex ELISA for the detection of Mycoplasma bovis infections in cattle

open access: yesFrontiers in Veterinary Science
Early and accurate detection of infection with Mycoplasma bovis (M. bovis) is critical for managing disease caused by this pathogen, particularly in eradication campaigns, such as New Zealand’s National M. bovis Eradication Programme.
Yoichi Furuya   +11 more
doaj   +1 more source

Duplex real-time PCR assay targeting insertion elements IS1081 and IS6110 for detection of mycobacterium bovis in lymph nodes of cattle [PDF]

open access: yesBiotechnology in Animal Husbandry, 2014
The development of a reliable and rapid screening test for detection of Mycobacterium bovis (M. bovis) helps in control of bovine tuberculosis. The aim of this study was evaluate a sensitive and specific assay for detecting M.
Selim Abdelfattah, El-Haig M., Gaede W.
doaj  

Trends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based Surveillance.

open access: yesPLoS Neglected Tropical Diseases, 2015
BackgroundMycobacterium tuberculosis causes the majority of tuberculosis (TB) cases in humans; however, in developing countries, human TB caused by M. bovis may be frequent but undetected. Human TB caused by M.
Miriam Bobadilla-del Valle   +12 more
doaj   +1 more source

Complete genome sequencing of mycoplasma bovis type strain ningxia-1 and systematic bioinformatic characterization for housekeeping-related genes [PDF]

open access: yesKafkas Universitesi Veteriner Fakültesi Dergisi, 2020
Mycoplasma bovis is a major pathogen leading to bovine respiratory disease syndrome. The worldwide prevalence of this pathogen has caused enormous economic losses in the beef industry.
Peng SUN   +5 more
doaj   +1 more source

Growth of Streptococcus bovis and a Butyrivibrio in batch and continuous culture and the relationship of molar growth yield to intermicrobial competition : a thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Microbiology. [PDF]

open access: yes, 1974
Cell growth yield of Streptococcus bovis and Butyrivibrio were determined in batch cultures where growth was separately limited by glucose, CO2 and trypticase.
Asmundson, Roderick Vincent
core  

Respiratory Organ‐on‐a‐Chip for Disease Modeling: From Architecture to Functional Integration

open access: yesAdvanced Healthcare Materials, EarlyView.
Respiratory organ‐on‐a‐chip (ROC) models capture key mechanical and cellular cues of the human respiratory system, enabling quantitative dissection of disease mechanisms. This review links ROC architectures to disease modeling, functional integration, and commercialization, and proposes a decision framework that aligns model complexity with mechanistic
Jinzhuo Hu   +4 more
wiley   +1 more source

Complete Genome Sequences of Field Isolates of Mycobacterium bovis and Mycobacterium caprae [PDF]

open access: yes, 2015
Here we report the complete genome sequences of field isolates of Mycobacterium bovis and the related mycobacterial species, Mycobacterium caprae. The genomes of three M. bovis (MB1, MB3, MB4) and one M.
Cabezas-Cruz, Alejandro   +13 more
core   +4 more sources

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

open access: yesAdvanced Materials, EarlyView.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa   +3 more
wiley   +1 more source

Macrophage Extracellular Traps in Immunity and Cancer

open access: yesAdvanced Science, EarlyView.
As a macrophage‐mediated innate defense mechanism, the dysregulated release of METs drives chronic inflammation and influences tumor progression. Furthermore, METs exhibit a functional duality within the tumor microenvironment, capable of both promoting and suppressing tumor development.
Junyao Li   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy